Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/128423 |
Resumo: | Management of pharmacotherapy in elderly with metabolic diseases is challenging and potentially inappropriate medications (PIMs) are risk factors for drug interactions and adverse events. The exposure to PIMs in elderly outpatients with metabolic diseases and its relationship with polypharmacy and other variables was investigated. PIMs prescribed to 207 elderly patients (aged 60 to 96 years) with metabolic diseases who attended a University Hospital of Sao Paulo city, Brazil, from April/2010 to January/2011, were evaluated. PIMs were detected using both 2003 Beers and 2008 STOPP criteria. The association between PIMs and age, gender and polypharmacy was also examined. 2008 STOPP criteria detected more PIMs (44.4 %) than 2003 Beers criteria (16.0%, p |
id |
USP-31_29e67e072fb367dbb1e361c9fa3a3cee |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/128423 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases Management of pharmacotherapy in elderly with metabolic diseases is challenging and potentially inappropriate medications (PIMs) are risk factors for drug interactions and adverse events. The exposure to PIMs in elderly outpatients with metabolic diseases and its relationship with polypharmacy and other variables was investigated. PIMs prescribed to 207 elderly patients (aged 60 to 96 years) with metabolic diseases who attended a University Hospital of Sao Paulo city, Brazil, from April/2010 to January/2011, were evaluated. PIMs were detected using both 2003 Beers and 2008 STOPP criteria. The association between PIMs and age, gender and polypharmacy was also examined. 2008 STOPP criteria detected more PIMs (44.4 %) than 2003 Beers criteria (16.0%, pUniversidade de São Paulo. Faculdade de Ciências Farmacêuticas2016-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/12842310.1590/s1984-82502016000400014Brazilian Journal of Pharmaceutical Sciences; Vol. 52 Núm. 4 (2016); 699-707Brazilian Journal of Pharmaceutical Sciences; v. 52 n. 4 (2016); 699-707Brazilian Journal of Pharmaceutical Sciences; Vol. 52 No. 4 (2016); 699-7072175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/128423/125275Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessMartins, Vanessa dos SantosMori, Ana Luiza Pereira MoreiraDorea, Egidio LimaPinto, Gelba AlmeidaHirata, Mario HiroyukiHirata, Felipe Dominguez CrespoHirata, Rosario Dominguez Crespo2017-03-16T18:09:44Zoai:revistas.usp.br:article/128423Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2017-03-16T18:09:44Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases |
title |
Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases |
spellingShingle |
Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases Martins, Vanessa dos Santos |
title_short |
Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases |
title_full |
Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases |
title_fullStr |
Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases |
title_full_unstemmed |
Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases |
title_sort |
Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases |
author |
Martins, Vanessa dos Santos |
author_facet |
Martins, Vanessa dos Santos Mori, Ana Luiza Pereira Moreira Dorea, Egidio Lima Pinto, Gelba Almeida Hirata, Mario Hiroyuki Hirata, Felipe Dominguez Crespo Hirata, Rosario Dominguez Crespo |
author_role |
author |
author2 |
Mori, Ana Luiza Pereira Moreira Dorea, Egidio Lima Pinto, Gelba Almeida Hirata, Mario Hiroyuki Hirata, Felipe Dominguez Crespo Hirata, Rosario Dominguez Crespo |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Martins, Vanessa dos Santos Mori, Ana Luiza Pereira Moreira Dorea, Egidio Lima Pinto, Gelba Almeida Hirata, Mario Hiroyuki Hirata, Felipe Dominguez Crespo Hirata, Rosario Dominguez Crespo |
description |
Management of pharmacotherapy in elderly with metabolic diseases is challenging and potentially inappropriate medications (PIMs) are risk factors for drug interactions and adverse events. The exposure to PIMs in elderly outpatients with metabolic diseases and its relationship with polypharmacy and other variables was investigated. PIMs prescribed to 207 elderly patients (aged 60 to 96 years) with metabolic diseases who attended a University Hospital of Sao Paulo city, Brazil, from April/2010 to January/2011, were evaluated. PIMs were detected using both 2003 Beers and 2008 STOPP criteria. The association between PIMs and age, gender and polypharmacy was also examined. 2008 STOPP criteria detected more PIMs (44.4 %) than 2003 Beers criteria (16.0%, p |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/128423 10.1590/s1984-82502016000400014 |
url |
https://www.revistas.usp.br/bjps/article/view/128423 |
identifier_str_mv |
10.1590/s1984-82502016000400014 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/128423/125275 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso) info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso) |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 52 Núm. 4 (2016); 699-707 Brazilian Journal of Pharmaceutical Sciences; v. 52 n. 4 (2016); 699-707 Brazilian Journal of Pharmaceutical Sciences; Vol. 52 No. 4 (2016); 699-707 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222912872972288 |